Table 4. Testing Durations Across 3 Charts in Each Subgroup.
ETDRS Chart Type | Testing Duration, s | |||||||
---|---|---|---|---|---|---|---|---|
Group A (BCVA, 20/20-20/25) | Group B (BCVA, 20/20-20/40)a | Group C (BCVA, 20/50-20/100)a | Group D (BCVA, 20/125-20/200)a | |||||
First Test | Second Test | First Test | Second Test | First Test | Second Test | First Test | Second Test | |
Number | 33 | 33 | 38 | 36 | 37 | 37 | 51 | 43 |
Landolt C | 58 | 53 | 64 | 61 | 76 | 66 | 74 | 73 |
Alphabet | 39 | 37 | 41 | 41 | 42 | 42 | 48 | 52 |
P valueb | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | .001 | .002 |
Abbreviations: BCVA, best-corrected visual acuity; ETDRS, Early Treatment Diabetic Retinopathy Study.
Individuals with sight-threatening conditions including age-related cataract, diabetic macular edema, and age-related macular degeneration.
Testing durations were calculated using the Friedman test.